Von Hippel-Lindau protein promotes Skp2 destabilization on DNA damage

J. S. Roe, H. R. Kim, I. Y. Hwang, E. J. Cho, H. D. Youn

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)


Germline mutations in the von Hippel-Lindau (VHL) tumor suppressor gene cause VHL disease, a rare and autosomal-dominant genetic syndrome. Because VHL protein (pVHL) is the master regulator of hypoxia-inducible factor alpha (HIFα), the most prominent feature of VHL disease is the deregulation of HIFα proteins. However, the precise mechanism by which the loss of pVHL function contributes to tumorigenesis is not fully understood. Here, we show that pVHL destabilizes the F-box protein Skp2, a chief component of Skp, Cullin, F-box-containing complex that promotes DNA synthesis in the S phase. The Β-domain of pVHL interacts with Skp2, stimulating proteasome-dependent Skp2 degradation, but the destabilization of Skp2 does not depend on the E3 ubiquitin ligase activity of pVHL. Notably, the generation of DNA damage induces Skp2 degradation, which is attenuated by the suppression of endogenous pVHL expression. One possible mechanism of pVHL-dependent Skp2 degradation entails the antagonizing of Akt-mediated Skp2 phosphorylation, which maintains Skp2 stability. Reintroduction of VHL into VHL-null renal cell carcinoma (RCC) cells decreased Skp2 levels and restored DNA damage-dependent Skp2 degradation. These results identify the tumor suppressor function of pVHL in delaying the S-phase progression to inhibit cell proliferation on DNA damage. Clinically, this report explains as to why Skp2 accumulates abnormally in RCC tissues.

Original languageEnglish
Pages (from-to)3127-3138
Number of pages12
Issue number28
Publication statusPublished - 2011 Jul 14

Bibliographical note

Funding Information:
This work was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health and Welfare (0720460), the Korea Healthcare Technology R&D Project (A090281), and National Research Foundation Grant (NRF-2010-0018896) to H-DY, a grant from the Korea Healthcare R&D Project (A080181) to E-JC and by the Korea Student Aid Foundation (KOSAF) grant, funded by the Korea government (MEST) (S2-2008-000-00400-1) to JSR. We thank Dr B Bruene (Johann Wolfgang Goethe-University) and Dr DS Lim (KAIST) for invaluable materials.

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Genetics
  • Cancer Research


Dive into the research topics of 'Von Hippel-Lindau protein promotes Skp2 destabilization on DNA damage'. Together they form a unique fingerprint.

Cite this